Cowan KH - Search Results

1

A phase I study of topotecan followed sequentially by doxorubicin in patients with advanced malignancies.

Tolcher AW, O'Shaughnessy JA, Weiss RB, Zujewski J, Myhand RC, Schneider E, Hakim F, Gress R, Goldspiel B, Noone MH, Brewster LR, Gossard MR, Cowan KH. Tolcher AW, et al. Among authors: cowan kh. Clin Cancer Res. 1997 May;3(5):755-60. Clin Cancer Res. 1997. PMID: 9815746 Clinical Trial.

2

Phase I study of Taxol, doxorubicin, plus granulocyte-colony stimulating factor in patients with metastatic breast cancer.

Fisherman JS, McCabe M, Noone M, Ognibene FP, Goldspiel B, Venzon DJ, Cowan KH, O'Shaughnessy JA. Fisherman JS, et al. Among authors: cowan kh. J Natl Cancer Inst Monogr. 1993;(15):189-94. J Natl Cancer Inst Monogr. 1993. PMID: 7517154 Clinical Trial.

3

A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy.

O'Shaughnessy JA, Venzon DJ, Gossard M, Noone MH, Denicoff A, Tolcher A, Danforth D, Jacobson J, Keegan P, Miller L, Chow C, Goldspiel B, Cowan KH. O'Shaughnessy JA, et al. Among authors: cowan kh. Blood. 1995 Oct 15;86(8):2913-21. Blood. 1995. PMID: 7579383 Free article. Clinical Trial.

4

Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations.

Yang CJ, Horton JK, Cowan KH, Schneider E. Yang CJ, et al. Among authors: cowan kh. Cancer Res. 1995 Sep 15;55(18):4004-9. Cancer Res. 1995. PMID: 7664272

5

Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor.

Berg SL, Savarese DM, Balis FM, Denicoff AM, Hillig M, O'Shaughnessy JA, Poplack DG, Cowan KH. Berg SL, et al. Among authors: cowan kh. Cancer Res. 1993 Jun 1;53(11):2587-90. Cancer Res. 1993. PMID: 7684320 Clinical Trial.

6

Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer.

Ben-Baruch N, Denicoff AM, Goldspiel BR, O'Shaughnessy JA, Cowan KH. Ben-Baruch N, et al. Among authors: cowan kh. Invest New Drugs. 1993 Feb;11(1):71-4. doi: 10.1007/BF00873915. Invest New Drugs. 1993. PMID: 7688714 Clinical Trial.

7

Current status of paclitaxel in the treatment of breast cancer.

O'Shaughnessy JA, Cowan KH. O'Shaughnessy JA, et al. Among authors: cowan kh. Breast Cancer Res Treat. 1995;33(1):27-37. doi: 10.1007/BF00666068. Breast Cancer Res Treat. 1995. PMID: 7749130 Review.

8

Arterial thrombosis associated with granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy: a report of two cases.

Tolcher AW, Giusti RM, O'Shaughnessy JA, Cowan KH. Tolcher AW, et al. Among authors: cowan kh. Cancer Invest. 1995;13(2):188-92. doi: 10.3109/07357909509011689. Cancer Invest. 1995. PMID: 7874573 Review.

9

Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancer.

O'Shaughnessy JA, Fisherman JS, Cowan KH. O'Shaughnessy JA, et al. Among authors: cowan kh. Semin Oncol. 1994 Oct;21(5 Suppl 8):19-23. Semin Oncol. 1994. PMID: 7939757 Review.

10

Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer.

Pestalozzi BC, Sotos GA, Choyke PL, Fisherman JS, Cowan KH, O'Shaughnessy JA. Pestalozzi BC, et al. Among authors: cowan kh. Cancer. 1993 Mar 1;71(5):1797-800. doi: 10.1002/1097-0142(19930301)71:5<1797::aid-cncr2820710514>3.0.co;2-b. Cancer. 1993. PMID: 8095437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters